Skip to content

LS Pharma

Active
Private limited companyfounded 2021active for 4 yearsChaussée de Tirlemont, Sauv. 205, 5030 Gembloux, BelgiumKBO/BCE: BE 0779.459.534
Summary

LS Pharma has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €555,475 and a net result of €65,358. Equity is growing by about 16% per year across the filed financial years. Its solvency ranks better than 85% of 4,942 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysisFollow ReportCompare
LS PharmaActiveChecked score 96/100
Risk analysis ReportCompare

History

LS Pharma was incorporated on 28 December 2021 as a private limited company.1 Total assets rose from €609,684 in 2022 to €749,318 in 2025 and headcount from 2.1 to 2.8 full-time equivalents.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2022 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
13-04
NBB filing Annual accounts filed
financial year 2025 · full format
2025
31-12
Financial Equity above €500,000equity €555,475 ▲13.3%
A profit in every financial year since 2022 builds equity to €555,475.
17-06
NBB filing Annual accounts filed
financial year 2024 · full format
2024
07-06
NBB filing Annual accounts filed
financial year 2023 · full format
2023
28-03
NBB filing Annual accounts filed
financial year 2022 · full format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

We would like to set cookies. That happens only with your consent. What we measure